' stroke-width='2' stroke-linecap='round' stroke-miterlimit='10' d='M4 7h22M4 15h22M4 23h22'/%3E%3C/svg%3E)
Patient Experience
These patients have all received CAR T-cell therapy for non-Hodgkin’s lymphoma (NHL). For patients with other types of blood cancer, their experience is similar. To hear the personal stories of these individuals, click below.
Jacquie
Jacquie received a diagnosis of diffuse large B-cell lymphoma (DLBCL) in 2019. She explains her treatment journey to date, from initial treatment, to finding out she was eligible for CAR T and going through the process of receiving therapy.
Kathy
Kathy was diagnosed with DLBCL in 2019. She explains her journey with CAR T-cell therapy starting from T cell collection to the monitoring and follow-up process of receiving a clear 90-day scan.
Neil
Neil was diagnosed with transformed follicular lymphoma and received news that his initial treatment was unsuccessful. While this was concerning, it opened up new doors for Neil as he was eligible for CAR T-cell therapy.
Alexander
In 2020, Alexander received his DLBCL diagnosis. He explains his CAR T infusion experience and how he has been feeling since receiving treatment.
